Literature DB >> 14707456

Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas.

Satoru Shintani1, Chunnun Li, Mariko Mihara, Satoshi Hino, Koh-Ichi Nakashiro, Hiroyuki Hamakawa.   

Abstract

Previous studies have shown that low levels of p27(KIP1), an inhibitor of G1 cyclin-dependent kinases (CDK), are associated with high aggressiveness and poor prognosis in a variety of cancers. Decreased levels of p27(KIP1) are caused, at least in part, by an acceleration of degradation with Skp2 (S-phase kinase-associated protein 2) and Jab1 (Jun activation domain-binding protein 1). This investigation was undertaken to examine whether the Skp2 and Jab1 expression is correlated with p27(KIP1) protein levels, and how it is clinically relevant in oral squamous cell carcinoma (OSCC). The correlations between p27(KIP1) and Skp2, and p27(KIP1) and Jab1 expression were evaluated by Western blot analysis. Immunohistochemical analysis was done in 75 cases of OSCC. A strongly significant inverse correlation was found between levels of p27(KIP1) and Skp2, and p27(KIP1) and Jab1 (p < 0.0001). Thus, decreased levels of p27(KIP1) were associated with strongly increased levels of Skp2 and Jab1, whereas high levels of p27(KIP1) coincided with low levels of Skp2 and Jab1. Reductions of p27(KIP1) expression and overexpression of Skp2 and Jab1 were significantly associated with cervical lymph node metastasis and poor prognosis. Overexpression of Skp2 and Jab1 is associated with the reduction of p27(KIP1) expression, and may have a role in the progression of OSCC. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14707456     DOI: 10.1159/000074649

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  16 in total

1.  Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27.

Authors:  Ling Gao; Shuo Huang; Wenhao Ren; Lu Zhao; Jingwei Li; Keqian Zhi; Yincheng Zhang; Hong Qi; Chen Huang
Journal:  Med Oncol       Date:  2012-02-04       Impact factor: 3.064

2.  Adhesion to fibronectin induces p27(Kip1) nuclear accumulation through down-regulation of Jab1 and contributes to cell adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells.

Authors:  Min Fei; Qinglei Hang; Sicong Hou; Songbin He; Changgeng Ruan
Journal:  Mol Cell Biochem       Date:  2013-10-30       Impact factor: 3.396

3.  Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance.

Authors:  Liansheng Qiu; Jiabao Lv; Yimin Chen; Jiarong Wang; Ruishan Wu
Journal:  Oncol Lett       Date:  2015-10-12       Impact factor: 2.967

4.  Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.

Authors:  Yufu Zhu; Zhichao Qiu; Xiang Zhang; Fengyuan Qian; Bin Wang; Lei Wang; Hengliang Shi; Rutong Yu
Journal:  J Neurooncol       Date:  2016-09-17       Impact factor: 4.130

5.  Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.

Authors:  Maria A Kouvaraki; Anita L Korapati; George Z Rassidakis; Ling Tian; Qingxiu Zhang; Paul Chiao; Linus Ho; Douglas B Evans; François X Claret
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

Review 6.  The emerging role of the COP9 signalosome in cancer.

Authors:  Katharine S Richardson; Wayne Zundel
Journal:  Mol Cancer Res       Date:  2005-12       Impact factor: 5.852

7.  JAB1/CSN5: a new player in cell cycle control and cancer.

Authors:  Terry J Shackleford; Francois X Claret
Journal:  Cell Div       Date:  2010-10-18       Impact factor: 5.130

8.  Dynamic changes of Jab1 and p27kip1 expression in injured rat sciatic nerve.

Authors:  Xinghai Cheng; Zhengming Zhou; Guangfei Xu; Jing Zhao; Hao Wu; Long Long; Hai Wen; Xingxing Gu; Youhua Wang
Journal:  J Mol Neurosci       Date:  2013-01-31       Impact factor: 3.444

9.  Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma.

Authors:  You Wang; Yuchan Wang; Chun Cheng; Yuhong Ji; Yueming Zhao; Lin Zou; Aiguo Shen
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-13       Impact factor: 4.553

Review 10.  Targeting Jab1/CSN5 in nasopharyngeal carcinoma.

Authors:  Yunbao Pan; Francois X Claret
Journal:  Cancer Lett       Date:  2012-08-04       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.